LRP6 and neurodegenerative disease: Considering that dysregulation of the Wnt/β-catenin pathway has been reported in many neurodegenerative diseases, the LRP6 is a promising therapeutic target in other neurodegenerative diseases (Liu et al., 2014; Lengfeld et al., 2017; Lim et al., 2017).